FIELD: pharmacology.
SUBSTANCE: invention is a method for the treatment of mixed dyslipidemia in a subject receiving treatment with statins. Herewith the method includes administration of 4 capsules per day to the subject in the fasted state. Each capsule contains of 900 mg, 925 mg, 950 mg, 975 mg or 1 g ethyl-EPA to reduce triglycerides and LDL-C in a subject relative to subjects with mixed dyslipidemia who receive statins without ethyl-EPA.
EFFECT: reduced level of triglycerides and LDL-C levels in subjects with mixed dyslipidemia of different intensity.
13 cl, 1 ex, 4 dwg
